First Time Loading...

ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 0.1698 USD -4.61% Market Closed
Updated: Apr 28, 2024

ReShape Lifesciences Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ReShape Lifesciences Inc
Cash from Financing Activities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
ReShape Lifesciences Inc
NASDAQ:RSLS
Cash from Financing Activities
$17.6m
CAGR 3-Years
244%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Financing Activities
-$2.3B
CAGR 3-Years
-144%
CAGR 5-Years
4%
CAGR 10-Years
-10%
Boston Scientific Corp
NYSE:BSX
Cash from Financing Activities
$5m
CAGR 3-Years
-74%
CAGR 5-Years
-68%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Cash from Financing Activities
-$1.6B
CAGR 3-Years
-425%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Cash from Financing Activities
-$7.1B
CAGR 3-Years
-33%
CAGR 5-Years
-7%
CAGR 10-Years
-9%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Financing Activities
$46.9m
CAGR 3-Years
N/A
CAGR 5-Years
-13%
CAGR 10-Years
N/A

See Also

What is ReShape Lifesciences Inc's Cash from Financing Activities?
Cash from Financing Activities
17.6m USD

Based on the financial report for Dec 31, 2023, ReShape Lifesciences Inc's Cash from Financing Activities amounts to 17.6m USD.

What is ReShape Lifesciences Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
12%

Over the last year, the Cash from Financing Activities growth was 461%. The average annual Cash from Financing Activities growth rates for ReShape Lifesciences Inc have been 244% over the past three years , 12% over the past five years .